Page 57 - Genentech News Today

An injectable drug already approved for asthma and chronic hives protects against bad reactions to peanuts, eggs, milk, and other foods, early analysis shows.

An injectable drug already approved for asthma and chronic hives protects against bad reactions to peanuts, eggs, milk, and other foods, early analysis shows.

An injectable drug already approved for asthma and chronic hives protects against bad reactions to peanuts, eggs, milk, and other foods, early analysis shows.

An injectable drug already approved for asthma and chronic hives protects against bad reactions to peanuts, eggs, milk, and other foods, early analysis shows.

Primary Hyperoxaluria Treatment MarketThe global primary hyperoxaluria treatments market is expected to develop at a compound annual growth rate (CAGR) of 8.6% between 2023 and 2033, according to a recent market research analysis by Future Market Insights. By the end of the forecast year previously indicated, the ma...

SILVER SPRINGS, MD.-A drug that has already been approved for asthma and hives may protect people with food allergies from reactions to peanuts, eggs, milk and other foods.

An injectable drug already approved for asthma and chronic hives protects against bad reactions to peanuts, eggs, milk, and other foods, early analysis shows.

An injectable drug already approved for asthma and chronic hives protects against bad reactions to peanuts, eggs, milk, and other foods, early analysis shows.

An injectable drug already approved for asthma and chronic hives protects against bad reactions to peanuts, eggs, milk, and other foods, early analysis shows.

An existing asthma treatment shows promise for reducing food allergies in children and is one step closer to approval, which could come by the end of March. Early data from a federally funded clinical trial showed children who received injections of the monoclonal antibody omalizumab could consume higher doses of peanut, egg, milk and…